Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 22, 2004
French government adds new patient categories to reimbursement approval criteria.
-
Nov 18, 2004
Company plans to use the proceeds to repay commercial paper borrowings and for other general corporate purposes.
-
Nov 16, 2004
Equity investment in a privately held company developing a balloon-expandable, bioresorbable drug-eluting stent.
-
Nov 15, 2004
The two series of senior notes will have varied maturities and a combined aggregate principal amount of $500 million.
-
Nov 12, 2004
A live webcast and replay of the November 18 conference session will be available.
-
Nov 8, 2004Boston Scientific Announces Resumption of Distribution of Advanced Bionics Cochlear Auditory Implant
Company subsidiary will resume worldwide distribution after a voluntary recall of all unimplanted cochlear implant systems.
-
Nov 5, 2004
TAXUS™ Express2™ paclitaxel-eluting coronary stent system will be the subject of 15 presentations.
-
Nov 4, 2004
A live webcast and replay of the November 10 conference session will be available.
-
Nov 2, 2004
Patients with Gastroesophageal Reflux Disease (GERD) reported substantial improvements after the Enteryx® Procedure.
-
Nov 2, 2004
and Orlando, FL (November 2, 2004)-- Boston Scientific Corporation (NYSE: BSX) today announced results supporting the efficacy of the Enteryx Procedure in relieving the symptoms of...